特发性肺纤维化及病理学寻常型间质性肺炎患者的自身免疫特征评估:对CT模式与预后的意义
本研究回顾性纳入2013年1月至2020年2月经手术肺活检确诊为寻常型间质性肺炎的210例患者,比较不同CT模式下的自身免疫特征,并按现行指南诊断间质性肺炎伴自身免疫特征(IPAF)。结果显示,病理学或血清学自身免疫特征及IPAF在CT模式为不确定或替代诊断的患者中更常见,但IPAF并不能预测总生存期。
要点
- 在病理确诊为寻常型间质性肺炎的患者中,CT模式为不确定或替代诊断者IPAF患病率更高。
- IPAF并非总生存期的预测因素(HR 0.81,95%CI 0.38–1.72,P=0.58)。
- 淋巴滤泡、CTD的CT征象及使用抗纤维化药物与更高总生存期独立相关,而CT纤维化范围更大与更差总生存期相关。
核心结论
- 在特发性肺纤维化-病理学寻常型间质性肺炎患者中,血清学和病理学自身免疫特征与不确定或替代CT模式相关;某些组织病理学和影像学自身免疫特征(而非现行IPAF标准)与生存期相关。
研究设计与样本
- 回顾性研究,纳入2013年1月至2020年2月经手术肺活检确诊为寻常型间质性肺炎的210例患者(中位年龄64岁,IQR 60–68岁,158例男性),按现行指南诊断IPAF,评估CT征象并用Cox比例风险模型分析总生存期。
关键影像表现/征象
- CT模式为不确定或替代诊断的患者中,病理学自身免疫特征比例为38%(33/87),高于UIP或可能UIP模式患者的20.3%(25/123)(P=0.005)。
- CT模式为不确定或替代诊断的患者中,血清学自身免疫特征比例为20%(17/87),高于UIP或可能UIP模式患者的9.8%(12/123)(P=0.04)。
- CT模式为不确定或替代诊断的患者中,IPAF比例为21%(18/87),高于UIP或可能UIP模式患者的4.1%(5/123)(P<0.001)。
- 淋巴滤泡(HR 0.59,95%CI 0.37–0.93,P=0.02)、CTD的CT征象(HR 0.31,95%CI 0.09–0.99,P=0.047)及使用抗纤维化药物(HR 0.31,95%CI 0.19–0.51,P<0.001)与更高总生存期独立相关。
- CT纤维化范围更大与更差总生存期相关(HR 1.08,95%CI 1.05–1.11,P<0.001)。
诊断标准与关键数值
- IPAF按现行指南诊断,共23例(11.0%)符合。
- IPAF对总生存期无预测价值(HR 0.81,95%CI 0.38–1.72,P=0.58)。
临床应用与阅片要点
- 阅片时需注意CT模式为不确定或替代诊断的UIP患者中自身免疫特征(病理学、血清学及IPAF)更常见。
- 报告CT纤维化范围可能有助于预后评估,范围更大与更差总生存期相关。
- 识别CTD的CT征象(前上叶、直边、 exuberant蜂窝征)及淋巴滤泡等特征可能与更好生存期相关,但现行IPAF标准未显示预后价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background The clinical, radiologic, and prognostic implications of interstitial pneumonia with autoimmune features (IPAF) in patients with idiopathic interstitial pneumonia and pathologic usual interstitial pneumonia (UIP) have not been fully evaluated. Purpose To compare autoimmune features according to CT patterns for the diagnosis of idiopathic pulmonary fibrosis (IPF) and to assess the diagnostic and prognostic implications of IPAF in patients with IPF-UIP. Materials and Methods This retrospective study included patients with UIP confirmed by surgical lung biopsy between January 2013 and February 2020. Data regarding clinical, radiologic, and pathologic autoimmune features were collected, and patients were diagnosed with IPAF according to current guidelines. CT signs for connective tissue disease (CTD; anterior upper lobe, straightedge, and exuberant honeycombing signs) were also evaluated. Overall survival (OS) was evaluated using Cox proportional hazards models. Results Among 210 patients included (median age, 64 years; IQR, 60-68 years; 158 male patients), 23 (11.0%) had IPAF. Patients with an alternative diagnosis or CT pattern indeterminate for UIP showed a higher prevalence of autoimmune features that were pathologic (38% [33 of 87] vs 20.3% [25 of 123]; P = .005) and serologic (20% [17 of 87] vs 9.8% [12 of 123]; P = .04) and IPAF (4.1% [five of 123] vs 21% [18 of 87]; P < .001) compared with patients with UIP or probable UIP pattern. However, IPAF was not predictive of OS (hazard ratio [HR], 0.81; 95% CI: 0.38, 1.72; P = .58). Lymphoid follicles (HR, 0.59; 95% CI: 0.37, 0.93; P = .02), CT signs for CTD (HR, 0.31; 95% CI: 0.09, 0.99; P = .047), and use of an antifibrotic agent (HR, 0.31; 95% CI: 0.19, 0.51; P < .001) were independently associated with higher OS, and greater extent of fibrosis on CT scans was associated with worse OS (HR, 1.08; 95% CI: 1.05, 1.11; P < .001). Conclusion In patients with IPF-pathologic UIP, serologic and pathologic autoimmune features were associated with indeterminate or alternative CT patterns. Certain histopathologic and radiologic autoimmune features, but not current IPAF criteria, were associated with survival. © RSNA, 2025 Supplemental material is available for this article. See also the editorial by Ackman in this issue.
引用
- Park S, Choe J, Kim HC, et al. Evaluation of Autoimmune Features in Patients with Idiopathic Pulmonary Fibrosis and Pathologic Usual Interstitial Pneumonia: Implications for CT Patterns and Prognosis. Radiology. 2025. PMID: 40131107. doi:10.1148/radiol.242292
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。